INS and metabolic dysfunction-associated steatotic liver disease: Different studies tried to unearth risk factors in this specific population; those who are lean and affected by NAFLD are often younger, and, even if they have a lower prevalence of diabetes and metabolic syndrome than NAFLD overweight patients [17], they are insulin-resistant and have higher plasma triglyceride levels when compared with matched healthy controls [18].